Semaglutide can protect you from the risk of heart attack to

Clinical trial showed diabetes and weight loss drug reduced major heart events by 20 per cent. This is an incremental benefit over and above controlling weight and diabetes, say experts

Related Keywords

United States , India , American , Rakesh Yadav , Martin Holst Lange , Novo Nordisk , Development At Novo Nordisk , American Heart Association , India Institute Of Medical Sciences , Max Hospitals , Holst Lange , All India Institute , Medical Sciences ,